# EMBLAVEO
> **NDA217906** · New Drug Application · Sponsor: ABBVIE · Approved 2025-02-07
## Drug
- **FDA Application Number:** NDA217906
- **Application type:** New Drug Application
- **Brand name:** EMBLAVEO
- **Generic name:** AZTREONAM AND AVIBACTAM
- **Active ingredients:** AVIBACTAM SODIUM; AZTREONAM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2025-02-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217906)
---
*MORVS · CC0 1.0*